Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways

AM Yehia, EGE Elsakka, AI Abulsoud… - … -Research and Practice, 2023 - Elsevier
Multiple myeloma (MM) is a cancer of plasma cells that has been extensively studied in
recent years, with researchers increasingly focusing on the role of microRNAs (miRNAs) in …

[HTML][HTML] miR-214 as a key hub that controls cancer networks: small player, multiple functions

E Penna, F Orso, D Taverna - Journal of Investigative Dermatology, 2015 - Elsevier
MicroRNAs are short regulatory RNAs that are able to post-transcriptionally modulate gene
expression and that have crucial roles in the control of physiological and pathological …

Prognostic role of circulating exosomal miRNAs in multiple myeloma

S Manier, CJ Liu, H Avet-Loiseau, J Park… - Blood, The Journal …, 2017 - ashpublications.org
Exosomes, secreted by several cell types, including cancer cells, can be isolated from the
peripheral blood and have been shown to be powerful markers of disease progression in …

Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors

P Xuan, K Han, M Guo, Y Guo, J Li, J Ding, Y Liu… - PloS one, 2013 - journals.plos.org
Background The identification of human disease-related microRNAs (disease miRNAs) is
important for further investigating their involvement in the pathogenesis of diseases. More …

[PDF][PDF] RETRACTED: downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

F Pichiorri, SS Suh, A Rocci, L De Luca, C Taccioli… - Cancer cell, 2010 - cell.com
In multiple myeloma (MM), an incurable B cell neoplasm, mutation or deletion of p53 is
rarely detected at diagnosis. Using small-molecule inhibitors of MDM2, we provide evidence …

miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets

TP Lu, CY Lee, MH Tsai, YC Chiu, CK Hsiao, LC Lai… - 2012 - journals.plos.org
Background Many prediction tools for microRNA (miRNA) targets have been developed, but
inconsistent predictions were observed across multiple algorithms, which can make further …

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

WJ Chng, GF Huang, TH Chung, SB Ng… - Leukemia, 2011 - nature.com
Events mediating transformation from the pre-malignant monoclonal gammopathy of
undetermined significance (MGUS) to multiple myeloma (MM) are unknown. We analyzed …

Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma

Y Hu, J Lin, H Fang, J Fang, C Li, W Chen, S Liu… - Leukemia, 2018 - nature.com
Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a highly conserved
long non-coding RNA (lncRNA). Overexpression of MALAT1 has been demonstrated to …

[HTML][HTML] microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers

N Nohata, T Hanazawa, H Enokida, N Seki - Oncotarget, 2012 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are endogenous short non-coding RNA molecules that regulate gene
expression by repressing translation or cleaving RNA transcripts in a sequence-specific …

LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma

Y Gao, P Fang, WJ Li, J Zhang, GP Wang, DF Jiang… - Molecular …, 2020 - Elsevier
Background LncRNA NEAT1 was associated with the tumorigenesis of multiple myeloma
(MM). However, the mechanisms of M2 macrophage polarization involved with NEAT1 in …